Abstract
Comment on: Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1093/rheumatology/keae013
Journal: Rheumatology (Oxford, England) | Publication Date: Jan 15, 2024 |
Comment on: Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis.
Join us for a 30 min session where you can share your feedback and ask us any queries you have